![]() Emtora Biosciences Emtora Biosciences is a life science company developing eRap, a formulation of rapamycin for the prevention of cancer progression/recurrence. | ![]() Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. | ![]() Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. | ![]() OS Therapies OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma. | ||
Founding Date | Founding Date N/A | Founding Date 2006 | Founding Date 2014 | Founding Date 1997 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations San Antonio, US HQ | Locations Cambridge, US HQ | Locations Södertälje, SE HQ | Locations Pasadena, US HQ San Diego, US | Locations Rockville, US HQ |
Employees | Employees 2 | Employees 593% decrease | Employees 3 | Employees 2604% increase | Employees 4 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 5.7 k | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 55.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.6m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $125.6m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($33.2m) (FY, 2021) | Net income N/A | Net income ($92.1m) (FY, 2025) | Net income ($28.8m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 3m | Total funding raised $ 209.5m | Total funding raised N/A | Total funding raised $ 108.4m | Total funding raised $ 6m |

Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
View companyNoviga Research is a company developing a cancer treatment medications.
View company
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View company
OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma.
View company